About
Gene Matrix | Global Biotech Leader in Precision Genomics and AI Healthcare Gene Matrix is a next-generation biotechnology company transforming the landscape of healthcare through advanced genetic testing, pharmacogenomics, and AI-driven health intelligence. Headquartered in the United States with international operations across Europe, LATAM, and MENA, we deliver a turnkey ecosystem that bridges clinical genomics, digital health, and predictive medicine. Our mission is to empower people and health systems with personalized, preventive, and precision-driven care — using the blueprint of life: DNA. We offer over a dozen clinically validated genetic panels, including: GenePGx: Optimizes drug prescribing to reduce adverse reactions GeneCancer: Detects hereditary cancer risks before symptoms appear GeneMind: Screens for genetic factors affecting mental health GeneDiet, GeneHealth, GeneSport, GeneBaby, and more These tests are designed for hospitals, clinics, public health programs, and consumers. Results are delivered through our HIPAA/GDPR-compliant AI platform, which transforms complex genetic data into clear, actionable reports for doctors and patients. What sets Gene Matrix apart: ✅ Fully integrated from collection kits to AI-powered reporting ✅ Supports national-scale genomic programs ✅ Offers lab automation tools (e.g., Opentrons, MassARRAY) ✅ Delivers cost-saving strategies for healthcare systems ✅ Enables medical tourism, insurance partnerships, and regional R&D Our pharmacogenomic test, GenePGx, has been shown to reduce trial-and-error prescribing by up to 45%, while our early detection panels have saved partners millions in downstream cancer treatment costs. We are more than a lab — we are a full-service genomics and biotech partner dedicated to making healthcare more intelligent, efficient, and personalized worldwide.
Product
- Value proposition
- Hereditary cancer genetic testing and precision genomics solutions delivered to patients and healthcare providers worldwide, with rapid results (within 72 hours) and AI-powered analysis.
- Target customers
- Patients and healthcare providers seeking hereditary cancer testing and precision genomics insights
- Pricing
- Subscription (starting at $69/month)
Founders
- Tarek Younis
Categories
Products
Key features
Technologies
Integrations
Target conditions
Care settings
Certifications
Traction metrics
Competitors
Investors
News
- Genetic Testing Service Area — Chicago, IL & Illinois | Gene Matrix · 2026-04-24T00:00:00.000Z
- Precision medicine trends and AI solutions for 2026 · 2026-04-09T20:11:50.000Z
- Gene Matrix Unveils GeneMatrix AI™: Revolutionary AI-Powered Platform Transforming Precision Medicine Globally · 2025-08-25T17:34:28.000Z
- Gene Matrix Launches GeneMatrixAI™: A Revolutionary Leap in Genetic Reporting · 2025-07-09T21:49:23.000Z
- Gene Matrix Launches as Global Biotech Leader in Genomics, AI, and Preventive Health | FinancialContent · 2025-06-06T19:44:01.000Z
- Gene Matrix Announces Global Expansion and Upcoming Series A Funding Round for AI-Powered Genomics Platform · 2025-10-02T21:00:32.000Z
Browse similar startups
Related startups
- Genix Therapeutics — Chicago, IL
- HAHN PEDIATRIC GROUP, LLC — Tinley Park, IL
- Heartful Sprout — chicago, IL
- Ingenio Care, Inc. — Lombard, IL
- JM Dental — Woodridge, IL
- Kardiolytics Inc. — Chicago, IL
- GENITECH LLC — Dallas, TX
- Gennao Bio — Hopewell, NJ
- Genomes2People — Boston, MA
- Genoxus — San Diego, CA
- Gismo Therapeutics (United States) — Lexington, KY
- Give Virtual Care — Scottsdale, AZ
Profile updated Jul 29, 2026. Sources: genematrix.io
